IVim Technology

IVim Technology Interest Coverage

The Interest Coverage Ratio of IVim Technology (460470.KQ) as of Nov 15, 2026 is -11.80. In the previous year, Interest Coverage Ratio was -2.02 — a change of 484.94% (lower).

Interest Coverage

-11.80

YoY

484.94%

Last updated:

Interest Coverage Ratio of IVim Technology is 2024 -11.80 . Interest Coverage Ratio of IVim Technology was 2023 -2.02 . It decreases by 484.94% lower compared to the previous year.

The IVim Technology Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2023
-2.02 KRW
Jan 1, 2024
-11.80 KRW
The IVim Technology Interest Coverage history
YEARInterest CoverageYoY
-11.80+484.94%
-2.02—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IVim Technology Stock analysis

What does IVim Technology do? IVim Technology Inc generates revenue through the development, manufacture, and sale of biological microscopes utilizing in vivo live cell imaging platform technology. The company offers imaging accessories and provides cellular-level imaging acquisition services inside living bodies along with kinetic analysis services for injected drugs. Its primary customers are healthcare institutions requiring advanced imaging solutions for research and diagnostic purposes. The firm targets the health care equipment and supplies industry segment focused on in vivo cellular analysis and drug development support. The company's core products include biological microscopes capable of analyzing complex dynamic changes in numerous cells in vivo, imaging accessories, and specialized services for cellular imaging and drug kinetics. These offerings are tailored to meet the needs of medical research facilities and pharmaceutical companies seeking to enhance their in vivo analysis capabilities. IVim Technology Inc's business model centers on providing integrated solutions for cellular-level imaging and drug efficacy assessment within the healthcare sector. Revenue streams are derived from direct sales of microscopes and accessories to healthcare providers and research institutions. The company also monetizes its expertise through service-based contracts for cellular imaging acquisition and kinetic drug analysis. These services are particularly valuable for pharmaceutical firms conducting preclinical studies and developing new treatments. The firm's focus on in vivo live cell imaging technology positions it as a key supplier for advanced medical research applications. IVim Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IVim Technology stock

Interest Coverage Ratio of IVim Technology is -11.80 in 2024.

Interest Coverage Ratio of IVim Technology changed from -2.02 to -11.80, representing a 484.94% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio IVim Technology since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's IVim Technology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — IVim Technology

All Key Metrics — IVim Technology